Japan-headquartered Atonarp has raised $50 million from a Series D funding round led by Silicon Valley-based investor WRVI Capital and supported by Furukawa Electric, Japan Post Investment, Boscolo ...
An important scientific study published in The Lancet shows the strong public health impact of deploying molecular diagnostics closer to the people.
New York, October 07, 2021 – Reports and Data has published its latest report titled “In-Vitro Diagnostics (IVD) Quality Control Market, By Product & Service Type (Quality Control Products, Whole ...
The company's Dragonfly instrument uses a proprietary sample preparation method and isothermal amplification to diagnose a variety of infectious diseases.
The Molecular Diagnostic and Assay Development Hub is focused on expanding our targeted and agnostic diagnostic capabilities against viral threats with pandemic potential. During the two-year start-up ...
The firm hopes to exploit its first-mover advantage in the OTC space following de novo clearance for an at-home PCR test to detect sexually transmitted infections.
In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.
Understanding molecular diversity is fundamental to biomedical research and diagnostics, but existing analytical tools ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback